Calleri 1998.
| Methods | Randomisation: yes Blinding: no Intention to treat: yes Methodological score: 8 | |
| Participants | ‐ Patients with acute hepatitis C ‐ n = 40 ‐ Arms (IFN/C): 20/20 ‐ RNA + at entry: no data available (NDA) ‐ Excluded: 0/0 ‐ Mean age (y): 29/29 ‐ Male (%): 85/85 ‐ Transfusion (%): 5/5 ‐ Drug abuse (%): 65/65 ‐ Genotype: NDA ‐ Mean disease duration (wk): NDA | |
| Interventions | ‐ Schedule: Control: no intervention Experimental: IFN beta 3 MU/day x 5 d; 3 MU tiw x 3 wk ‐Follow‐up (F/U): 22 mo | |
| Outcomes | ‐ Biochemical ETR and SR | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Allocation concealment? | Unclear risk | B ‐ Unclear |